HFM
CBAY

Harvest Fund Management’s Cymabay Therapeutics CBAY Stock Holding History

Harvest Fund Management’s Portfolio CBAY Stock Details CBAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,076
Closed -$26K – 795
2023
Q4 		$26K Buy
+1,076
New +$19.2K ﹤0.01% 479

Other funds holding CBAY

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Harvest Fund Management's CBAY Position: Q1 2024 in Review

Harvest Fund Management sold out of Cymabay Therapeutics (CBAY) in Q1 2024, closing a stake of 1,076 shares — an estimated $26K sold.

Harvest Fund Management first reported a position in CBAY in Q4 2023 and held it in 1 quarter. The position peaked at $26K in Q4 2023. 1 fund tracked by Wall St. Rank holds CBAY as of Q1 2024.

  • Harvest Fund Management reported no remaining Cymabay Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Harvest Fund Management sold 1,076 Cymabay Therapeutics shares in Q1 2024, an estimated $26K.
  • Harvest Fund Management first reported a position in Cymabay Therapeutics in Q4 2023 and held it in 1 quarter.
  • Harvest Fund Management's Cymabay Therapeutics position peaked at $26K in Q4 2023.
  • 1 fund tracked by Wall St. Rank held Cymabay Therapeutics as of Q1 2024.

Based on Harvest Fund Management's 13F filing for Q1 2024, filed 14 May 2024.